| Literature DB >> 31277671 |
Salma Bibi Kadiri1, Amy Pamela Kerr1, Nicola Katy Oswald2, Alina-Maria Budacan1, Sarah Flanagan3, Christopher Golby4, Stuart Lightfoot1, Babu Naidu5,6.
Abstract
BACKGROUND: Pulmonary rehabilitation programme for lung surgery patients can reduce the risk of post-operative complications but compliance to programmes can be limited by access to health care. We developed a home-based rehabilitation app and tested its feasibility in patients undergoing lung resection surgery.Entities:
Keywords: Exercise; Intervention; Lung Cancer; Pulmonary rehabilitation; Quality of life; Technology; Thoracic surgery
Mesh:
Year: 2019 PMID: 31277671 PMCID: PMC6611050 DOI: 10.1186/s13019-019-0951-6
Source DB: PubMed Journal: J Cardiothorac Surg ISSN: 1749-8090 Impact factor: 1.637
Fig. 1Screenshots from Fit 4 Surgery App. a training video for patients on how to use the app. b safety notification screen (c) one of the exercise videos which shows feedback e.g. duration of exercise, heart rate and O2 saturation. d one of the education videos that patients can view using the app. e a summary screen post exercise which shows if target heartrate was achieved, average O2 saturation and motivation feedback. f Additional comments box screenshot
Demographics
| App group ( | |
|---|---|
| Age, mean (SD) | 64 (12) |
| BMI, mean (SD) | 25.7 (9.6) |
| % predicted FEV1, mean (SD) | 74.2 (34) |
| Measured FVC, mean (SD) | 3.40 (1.14) |
| % predicted DLCO, | 68.2% |
| Pathology | |
| NSCLC | 54.8% (17) |
| Other lung Ca | 22.6% (7) |
| Metastatic | 3.2% (1) |
| Benign | 19.4% (6) |
| Self-reported pre- op activity level % (N) | |
| Able to walk < 400 m | 26% (8) |
| Able to walk at least 400 m | 19% (6) |
| Able to walk at least 2 km | 6% (2) |
| Able to walk > 2 Kilometres | 48% (15) |
| Smoking % (N) | |
| Never | 19.4% (6) |
| Ex > 6 weeks | 41.9% (13) |
| Ex< 6 weeks | 12.9% (4) |
| Current | 25.8% (8) |
| Ischaemic heart disease % (N) | 6.5% (2) |
| COPD % (N) | 27.6% (9) |
| mMRC score, median (IQR) | 1 (0–1) |
| ECOG performance status, median (IQR) | 0 (0–1) |
BMI Body Mass Index, FEV1 Forced expiratory volume, FVC Forced lung capacity, NSCLC Non-small cell lung cancer, DLCO Diffusing capacity of the lung for carbon monoxide, COPD Chronic Obstructive Pulmonary disease, ECOG the Eastern cooperative oncology group
Process measures
| App ( | Classes ( | |
|---|---|---|
| Days from screened to 1st rehab, median (IQR) | 6 (2–13) | 5 (0–23) |
| Days from rehab to surgery date, median (IQR) | 24 (13–33) | 45 (27–71) |
| Rehab sessions before surgery, median (IQR) | 9 (6–13) | 2 (1–8) |
| Days of rehab post-surgery, median (IQR) | 2 (0–7) | 0 (0–0) |
Fig. 2Incremental shuttle walk test before and after rehabilitation in app group. Each patient is represented by one line
EORTC QLQ C30 scores in the app group
| Domain | Change in scores pre surgery to 5 weeks post-surgery | Change in scores post op 5 weeks to 5 months |
|---|---|---|
| Physical | 19.0 (17.8) | −4.73 (27.7) |
| Role | 19.3 (30.2) | −4.98 (41.5) |
| Fatigue | −23.4 (26.4) | 3.88 (35.2) |
| Pain | −18.4 (33.2) | 15.7 (32.6) |
| Dyspnoea | −26.8 (28.0) | 1.7 (42.7) |
| Global Health status | 19.6 (19.1) | −10.0 (29.8) |
Mean (standard deviation) change in QOL scores from pre rehabilitation to 5 months post-surgery
Exercise parameters in app group
| App- exercise parameters | Median (%) | Range |
|---|---|---|
| Number of sessions pre-surgery | 9 | 1–37 |
| Number of sessions per week pre-surgery | 4 | 1–7 |
| Total exercise time (mins) pre-surgery | 158 | 3–1226 |
| Time spent in target heart rate of ≥60% (%) | 32 | 3–93 |
| Number of exercises pre -surgery | ||
| Upper body | 14.5 (46.3) | 1–73 |
| Lower body | 21.5 (53.7) | 1–71 |
| Median number of sessions post-surgery | 2 | 0–30 |
| Median number of sessions per week post-surgery | < 1 | 0–4 |
| Total exercise time (mins) post-surgery | 22 | 0–888 |
| Median Number of exercises post-surgery | ||
| Upper body | 4 (47) | 0–90 |
| Lower body | 5 (53) | 0–87 |
Outcome measures
| App ( | |
|---|---|
| Surgery % (N) | |
| Lobectomy | 48.4% (15) |
| Sublobar | 48.4% (15) |
| Pneumonectomy | 3.2% (1) |
| Analgesia % (N) | |
| Epidural | 41.9% (13) |
| Morphine infusion | 6.4% (2) |
| Paravertebral | 51.6% (16) |
| Surgical technique % (N) | |
| Thoracotomy | 45.2% (14) |
| VATS | 54.8% (17) |
| Length of stay, median (IQR) | 4 (3–7) |
| PPC rate % (N) | 9.7% (3) |
| Unplanned ITU rate % (N) | 6.4% (2) |
| Unplanned ITU LOS in days’ median (IQR) | 1.5 (1–2) |
| 30 day hospital readmission % (N) | 9.7% (3) |
| 30-day mortality % (N) | 0% (0) |
PPC Postoperative Pulmonary complication, ITU Intensive therapy unit, LOS length of stay, VATS video-assisted thoracosopic surgery